Events & Presentations

Upcoming Events
Date Event Details Remind Me
Sep 20, 2017
4:30 PM ET
Argos Therapeutics to Hold Conference Call to Discuss Update on the Phase 3 ADAPT Trial Presented at the ESMO 2017 Congress

Argos Therapeutics to Hold Conference Call to Discuss Update on the Phase 3 ADAPT Trial Presented at the ESMO 2017 Congress

Remind Me

Please sign up for Email alerts.


Presentations
Date Title
 
 
 
Archived Events
Date Event Details
Sep 12, 2017
8:00 AM ET
ESMO 2017 Presentation
Apr 18, 2017
4:30 PM ET
Argos Update Call
Feb 22, 2017
8:30 AM ET
Argos Therapeutics Conference Call
Dec 7, 2016
8:00 AM ET
Investor Day
Nov 14, 2016
8:30 AM ET
Argos Therapeutics, Inc. Third Quarter 2016 Financial Results Conference Call
= add file to Briefcase

Stock Quote

NASDAQ: ARGS
0.19
+ 0.01 (+5.71%)

Day High:
0.19

Day Low:
0.18

Volume:
3,701,714

4:00 PM ET on Sep 19, 2017
Delayed at least 20 minutes.

Tweets